Correlation Between Cyclo Therapeutics and Mallinckrodt Plc
Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and Mallinckrodt Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and Mallinckrodt Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclo Therapeutics and Mallinckrodt Plc, you can compare the effects of market volatilities on Cyclo Therapeutics and Mallinckrodt Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of Mallinckrodt Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and Mallinckrodt Plc.
Diversification Opportunities for Cyclo Therapeutics and Mallinckrodt Plc
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cyclo and Mallinckrodt is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and Mallinckrodt Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mallinckrodt Plc and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with Mallinckrodt Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mallinckrodt Plc has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and Mallinckrodt Plc go up and down completely randomly.
Pair Corralation between Cyclo Therapeutics and Mallinckrodt Plc
Given the investment horizon of 90 days Cyclo Therapeutics is expected to generate 0.46 times more return on investment than Mallinckrodt Plc. However, Cyclo Therapeutics is 2.17 times less risky than Mallinckrodt Plc. It trades about -0.01 of its potential returns per unit of risk. Mallinckrodt Plc is currently generating about -0.21 per unit of risk. If you would invest 147.00 in Cyclo Therapeutics on August 31, 2024 and sell it today you would lose (83.00) from holding Cyclo Therapeutics or give up 56.46% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 8.56% |
Values | Daily Returns |
Cyclo Therapeutics vs. Mallinckrodt Plc
Performance |
Timeline |
Cyclo Therapeutics |
Mallinckrodt Plc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cyclo Therapeutics and Mallinckrodt Plc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyclo Therapeutics and Mallinckrodt Plc
The main advantage of trading using opposite Cyclo Therapeutics and Mallinckrodt Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, Mallinckrodt Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mallinckrodt Plc will offset losses from the drop in Mallinckrodt Plc's long position.Cyclo Therapeutics vs. cbdMD Inc | Cyclo Therapeutics vs. Gelteq Limited Ordinary | Cyclo Therapeutics vs. cbdMD Inc | Cyclo Therapeutics vs. Harrow Health |
Mallinckrodt Plc vs. Lifecore Biomedical | Mallinckrodt Plc vs. Shuttle Pharmaceuticals | Mallinckrodt Plc vs. Organogenesis Holdings | Mallinckrodt Plc vs. Journey Medical Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |